 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
| «123456789101112» |
- | alendronate / Generic mfg.
New P2 trial: Evaluation, the Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) Wif Alendronate in the Preservation of the Tooth Socket (clinicaltrials.gov) - Jun 12, 2019
P2, N=20, Completed, Sponsor: Islamic Azad University, Tehran
- | alendronate / Generic mfg.
Trial completion date: Stem Cell Recruitment in Osteoporosis Therapy (clinicaltrials.gov) - May 24, 2019
P=N/A, N=46, Active, not recruiting, Sponsor: Johns Hopkins University
Trial completion date: Aug 2019 --> Aug 2020
- || Prolia (denosumab) / Amgen, Daiichi Sankyo
Trial completion date, Trial primary completion date: Denosumab Safety Assessment in Multiple Observational Databases (clinicaltrials.gov) - May 3, 2019
P=N/A, N=508215, Active, not recruiting, Sponsor: Amgen
Trial completion date: Aug 2019 --> Aug 2020 Trial completion date: May 2020 --> Jun 2023 | Trial primary completion date: May 2020 --> Jun 2023
- | alendronate / Generic mfg.
Trial initiation date: 64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy (clinicaltrials.gov) - Apr 17, 2019
P1, N=6, Not yet recruiting, Sponsor: City of Hope Medical Center
Trial completion date: May 2020 --> Jun 2023 | Trial primary completion date: May 2020 --> Jun 2023 Initiation date: Jan 2019 --> Jul 2019
- | Prolia (denosumab) / Amgen, Daiichi Sankyo
Enrollment open, Trial initiation date: Comparative Antiresorptive Efficacy Discontinuation of Denosumab (clinicaltrials.gov) - Feb 18, 2019
P4, N=50, Recruiting, Sponsor: Massachusetts General Hospital
Initiation date: Jan 2019 --> Jul 2019 Not yet recruiting --> Recruiting | Initiation date: Sep 2018 --> Nov 2018
- | risedronate / Generic mfg., alendronate / Generic mfg., ibandronate sodium hydrate / Generic mfg.
Enrollment change: Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis (clinicaltrials.gov) - Feb 15, 2019
P=N/A, N=86, Completed, Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
Not yet recruiting --> Recruiting | Initiation date: Sep 2018 --> Nov 2018 N=200 --> 86
- | alendronate / Generic mfg.
Trial completion: PROSA: Predictive Value of Bone Turnover Markers During Discontinuation With Alendronate (clinicaltrials.gov) - Feb 1, 2019
P=N/A, N=136, Completed, Sponsor: Aarhus University Hospital
N=200 --> 86 Active, not recruiting --> Completed
- | alendronate / Generic mfg.
Trial completion date, Trial primary completion date: Pilot Study of Bisphosphonates for Breast Cancer (clinicaltrials.gov) - Jan 17, 2019
P1, N=20, Recruiting, Sponsor: University of Wisconsin, Madison
Active, not recruiting --> Completed Trial completion date: Aug 2019 --> Aug 2020 | Trial primary completion date: Jan 2019 --> Jan 2020
- | raloxifene hydrochloride / Generic mfg., alendronate / Generic mfg.
Enrollment open: Osteoporosis Treatment in Post-menopausal Women (clinicaltrials.gov) - Jan 14, 2019
P4, N=500, Recruiting, Sponsor: Taichung Veterans General Hospital
Trial completion date: Aug 2019 --> Aug 2020 | Trial primary completion date: Jan 2019 --> Jan 2020 Not yet recruiting --> Recruiting
- | alendronate / Generic mfg.
Trial completion date: PROSA: Predictive Value of Bone Turnover Markers During Discontinuation With Alendronate (clinicaltrials.gov) - Jan 9, 2019
P=N/A, N=140, Active, not recruiting, Sponsor: Aarhus University Hospital
Not yet recruiting --> Recruiting Trial completion date: Jul 2019 --> Jan 2019
- | Trial completion, Trial completion date, Trial primary completion date: Exome Sequencing for Atypical Femoral Fractures (clinicaltrials.gov) - Dec 31, 2018
P=N/A, N=38, Completed, Sponsor: Washington University School of Medicine
Trial completion date: Jul 2019 --> Jan 2019 Enrolling by invitation --> Completed | Trial completion date: Jun 2018 --> Mar 2018 | Trial primary completion date: Jun 2018 --> Mar 2018
- | alendronate / Generic mfg.
Trial completion date, Trial primary completion date: ALOSTRA: Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis (clinicaltrials.gov) - Oct 16, 2018
P2, N=160, Recruiting, Sponsor: University of Aarhus
Enrolling by invitation --> Completed | Trial completion date: Jun 2018 --> Mar 2018 | Trial primary completion date: Jun 2018 --> Mar 2018 Trial completion date: Dec 2020 --> Jul 2021 | Trial primary completion date: Dec 2020 --> Jul 2021
- | alendronate / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide (clinicaltrials.gov) - Sep 26, 2018
P2, N=17, Completed, Sponsor: Northwestern University
Trial completion date: Dec 2020 --> Jul 2021 | Trial primary completion date: Dec 2020 --> Jul 2021 Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Aug 2016 | Trial primary completion date: Dec 2017 --> Aug 2016
- || Prolia (denosumab) / Amgen, Daiichi Sankyo
Trial primary completion date: Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study (clinicaltrials.gov) - Sep 17, 2018
P1, N=75, Recruiting, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Aug 2016 | Trial primary completion date: Dec 2017 --> Aug 2016 Trial primary completion date: Oct 2019 --> May 2020
- | zoledronic acid / Generic mfg., alendronate / Generic mfg.
Trial completion, Enrollment change: Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation (clinicaltrials.gov) - Aug 16, 2018
P2/3, N=111, Completed, Sponsor: Columbia University
Trial primary completion date: Oct 2019 --> May 2020 Active, not recruiting --> Completed | N=84 --> 111
- | Prolia (denosumab) / Amgen, Daiichi Sankyo
New P4 trial: Comparative Antiresorptive Efficacy Discontinuation of Denosumab (clinicaltrials.gov) - Aug 9, 2018
P4, N=50, Not yet recruiting, Sponsor: Massachusetts General Hospital
- | alendronate / Generic mfg.
Phase classification: Alendronate in Juvenile Osteoporosis (clinicaltrials.gov) - Jul 11, 2018
P2b, N=11, Completed, Sponsor: Medical University of South Carolina
Active, not recruiting --> Completed | N=84 --> 111 Phase classification: P2 --> P2b
- | alendronate / Generic mfg.
Trial completion date, Trial primary completion date: 99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis (clinicaltrials.gov) - Jun 12, 2018
P=N/A, N=206, Recruiting, Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase classification: P2 --> P2b Trial completion date: Dec 2019 --> Jun 2019 | Trial primary completion date: Dec 2019 --> Jun 2019
- | alendronate / Generic mfg.
New P1 trial: 64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy (clinicaltrials.gov) - May 31, 2018
P1, N=6, Not yet recruiting, Sponsor: City of Hope Medical Center
- | Prolia (denosumab) / Amgen
Enrollment open: Bisphosphonates for Prevention of Post-Denosumab Bone Loss (clinicaltrials.gov) - Apr 17, 2018
P2, N=34, Recruiting, Sponsor: Columbia University
Trial completion date: Dec 2019 --> Jun 2019 | Trial primary completion date: Dec 2019 --> Jun 2019 Not yet recruiting --> Recruiting
- | alendronate / Generic mfg.
Trial completion date: Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide (clinicaltrials.gov) - Mar 30, 2018
P2, N=17, Active, not recruiting, Sponsor: Northwestern University
Not yet recruiting --> Recruiting Trial completion date: Mar 2018 --> Jun 2018
- | alendronate / Generic mfg.
Trial completion: BOCOMEDEN: Bone Healing After Dental Extraction in Postmenopausal Osteoporotic Women Treated With Alendronate Per os Weekly (clinicaltrials.gov) - Mar 19, 2018
P=N/A, N=66, Completed, Sponsor: Assistance Publique - Hôpitaux de Paris
Trial completion date: Mar 2018 --> Jun 2018 Active, not recruiting --> Completed
- | zoledronic acid / Generic mfg., alendronate / Generic mfg.
Trial completion, Enrollment change: Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants (clinicaltrials.gov) - Mar 19, 2018
P=N/A, N=59, Completed, Sponsor: University of Nebraska
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=110 --> 59
- |||| risedronate / Generic mfg., alendronate / Generic mfg., ibandronate sodium hydrate / Generic mfg.
Trial completion: Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects (clinicaltrials.gov) - Mar 6, 2018
P2, N=410, Completed, Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
Active, not recruiting --> Completed | N=110 --> 59 Active, not recruiting --> Completed
- alendronate / Generic mfg.
Trial completion date, Trial primary completion date: Testosterone and Alendronate in Hypogonadal Men (clinicaltrials.gov) - Feb 26, 2018
P2, N=100, Suspended, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed Trial primary completion date: Jun 2017 --> Jun 2019 | Trial completion date: Jun 2017 --> Jun 2019
- | alendronate / Generic mfg.
Trial completion date, Trial primary completion date: Pilot Study of Bisphosphonates for Breast Cancer (clinicaltrials.gov) - Feb 22, 2018
P1, N=20, Recruiting, Sponsor: University of Wisconsin, Madison
Trial primary completion date: Jun 2017 --> Jun 2019 | Trial completion date: Jun 2017 --> Jun 2019 Trial primary completion date: Jan 2018 --> Jan 2019 | Trial completion date: Aug 2018 --> Aug 2019
- | alendronate / Generic mfg.
New trial, Patient reported outcomes: Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes (clinicaltrials.gov) - Feb 15, 2018
P=N/A, N=80, Not yet recruiting, Sponsor: Labatec Pharma SA
- | alendronate / Generic mfg.
Enrollment closed: PROSA: Predictive Value of Bone Turnover Markers During Discontinuation With Alendronate (clinicaltrials.gov) - Jan 24, 2018
P=N/A, N=140, Active, not recruiting, Sponsor: Aarhus University Hospital
Trial primary completion date: Jan 2018 --> Jan 2019 | Trial completion date: Aug 2018 --> Aug 2019 Recruiting --> Active, not recruiting
- | alendronate / Generic mfg.
Trial primary completion date: 99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis (clinicaltrials.gov) - Jan 12, 2018
P=N/A, N=206, Recruiting, Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Recruiting --> Active, not recruiting Trial primary completion date: Dec 2017 --> Dec 2019
- ||| alendronate / Generic mfg.
Enrollment closed: BLADE-PCI Trial (BLADE); PHASE IIB LIPOSOMAL ALENDRONATE STUDY (clinicaltrials.gov) - Jan 11, 2018
P2b, N=270, Active, not recruiting, Sponsor: BIOrest Ltd.
Trial primary completion date: Dec 2017 --> Dec 2019 Recruiting --> Active, not recruiting
- | Prolia (denosumab) / Amgen
New P2 trial: Bisphosphonates for Prevention of Post-Denosumab Bone Loss (clinicaltrials.gov) - Jan 10, 2018
P2, N=34, Not yet recruiting, Sponsor: Columbia University
- || Prolia (denosumab) / Amgen, Daiichi Sankyo
Trial primary completion date: Denosumab Safety Assessment in Multiple Observational Databases (clinicaltrials.gov) - Dec 7, 2017
P=N/A, N=575462, Active, not recruiting, Sponsor: Amgen
Recruiting --> Active, not recruiting Trial primary completion date: May 2023 --> May 2020
- | Trial primary completion date: Exome Sequencing for Atypical Femoral Fractures (clinicaltrials.gov) - Nov 9, 2017
P=N/A, N=36, Enrolling by invitation, Sponsor: Washington University School of Medicine
Trial primary completion date: May 2023 --> May 2020 Trial primary completion date: Apr 2017 --> Jun 2018
- | Prolia (denosumab) / Amgen, Daiichi Sankyo
Enrollment open: Denosumab Versus Bisphosphonates (Alendronate) in GIOP (clinicaltrials.gov) - Oct 11, 2017
P4, N=220, Recruiting, Sponsor: Tuen Mun Hospital
Trial primary completion date: Apr 2017 --> Jun 2018 Not yet recruiting --> Recruiting
- |||||| Prolia (denosumab) / Amgen, Daiichi Sankyo
Enrollment open: Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study (clinicaltrials.gov) - Sep 26, 2017
P, N=75, Recruiting, Sponsor: Massachusetts General Hospital
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | alendronate / Generic mfg.
Enrollment closed, Enrollment change, Trial primary completion date: Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide (clinicaltrials.gov) - Sep 13, 2017
P2, N=17, Active, not recruiting, Sponsor: Northwestern University
Not yet recruiting --> Recruiting Enrolling by invitation --> Active, not recruiting | N=30 --> 17 | Trial primary completion date: Mar 2017 --> Dec 2017
- ||||||| Evenity (romosozumab) / Astellas, Amgen, UCB
Trial completion: ARCH: Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis (clinicaltrials.gov) - Jul 27, 2017
P3, N=4093, Completed, Sponsor: Amgen
Enrolling by invitation --> Active, not recruiting | N=30 --> 17 | Trial primary completion date: Mar 2017 --> Dec 2017 Active, not recruiting --> Completed
- | alendronate / Generic mfg.
Enrollment change, Trial primary completion date: BILANZ: Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy (clinicaltrials.gov) - Jul 12, 2017
P3, N=436, Terminated, Sponsor: Evangelisches Krankenhaus Lutherhaus gGmbH
Active, not recruiting --> Completed N=7000 --> 436 | Trial primary completion date: Dec 2014 --> Mar 2013
- | alendronate / Generic mfg.
Trial completion: Bone Loss in Premenopausal Women With Depression (clinicaltrials.gov) - Jun 30, 2017
P4, N=220, Completed, Sponsor: National Institute of Mental Health (NIMH)
N=7000 --> 436 | Trial primary completion date: Dec 2014 --> Mar 2013 Recruiting --> Completed
- | alendronate / Generic mfg.
Trial completion: Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome (clinicaltrials.gov) - Jun 30, 2017
P2, N=40, Completed, Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting --> Completed Active, not recruiting --> Completed
- | alendronate / Generic mfg.
New P2/3 trial: Local Host Modulating Agents Alendronate & Aloe Vera for Treatment of Furcation Defects in Chronic Periodontitis (clinicaltrials.gov) - Jun 29, 2017
P2/3, N=90, Completed, Sponsor: Government Dental College and Research Institute, Bangalore
- | alendronate / Generic mfg.
Trial completion, Trial initiation date: Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and Adolescents (clinicaltrials.gov) - Jun 14, 2017
P2, N=52, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed | Initiation date: Aug 2009 --> Nov 2009
- | alendronate / Generic mfg.
Trial primary completion date: ALOSTRA: Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis (clinicaltrials.gov) - Jun 2, 2017
P2, N=160, Recruiting, Sponsor: University of Aarhus
Active, not recruiting --> Completed | Initiation date: Aug 2009 --> Nov 2009 Trial primary completion date: Mar 2019 --> Dec 2020
- | alendronate / Generic mfg.
Trial primary completion date: Pilot Study of Bisphosphonates for Breast Cancer (clinicaltrials.gov) - May 3, 2017
P1, N=20, Recruiting, Sponsor: University of Wisconsin, Madison
Trial primary completion date: Mar 2019 --> Dec 2020 Trial primary completion date: Jan 2017 --> Jan 2018
- ||||||| Tymlos (abaloparatide) / Radius, Teijin
Trial completion: ACTIVExtend: Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis (clinicaltrials.gov) - Apr 13, 2017
P3, N=1200, Completed, Sponsor: Radius Health, Inc.
Trial primary completion date: Jan 2017 --> Jan 2018 Active, not recruiting --> Completed
- | alendronate / Generic mfg.
Trial completion: Alendronate Osteoporosis Study (clinicaltrials.gov) - Apr 11, 2017
P2/3, N=20, Completed, Sponsor: Boston Children’s Hospital
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| alendronate / Generic mfg.
Trial completion: FACT: A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211) (clinicaltrials.gov) - Mar 28, 2017
P3, N=1053, Completed, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed No longer recruiting --> Completed
- ||||||| risedronate / Generic mfg., alendronate / Generic mfg.
Trial completion: A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907) (clinicaltrials.gov) - Mar 27, 2017
P3, N=936, Completed, Sponsor: Merck Sharp & Dohme Corp.
No longer recruiting --> Completed No longer recruiting --> Completed
- ||||||| alendronate / Generic mfg.
Trial completion: A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219) (clinicaltrials.gov) - Mar 27, 2017
P3, N=454, Completed, Sponsor: Merck Sharp & Dohme Corp.
No longer recruiting --> Completed No longer recruiting --> Completed
- alendronate / Generic mfg.
New trial: PROSA: Predictive Value of Bone Turnover Markers During Discontinuation With Alendronate (clinicaltrials.gov) - Feb 14, 2017
P=N/A, N=140, Recruiting, Sponsor: Aarhus University Hospital